they simply won't get shares as the hurdle is not met. Its normal that listed company did not perform as good as what their prospectus says. I can accept some delays in revenue or FDA/CE Mark clearance as long as they did not lie or mislead about the effectiveness of the product.
LTI, page-2
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $7.298K | 36.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2090 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 7938 | 2 |
View Market Depth
| Last trade - 10.41am 27/09/2024 (20 minute delay) ? |
| NXS (ASX) Chart |